27-Oct-2026 19:06:04
CONCORDBIOGeneral news
CONCORD BIOTECH Q2 FY27 (CONS.) ; NET PROFIT UP 10.32% AT ₹69.57 CR (YOY), UP 20.58% (QOQ)
REVENUE UP 25.10% AT ₹309.07 CR (YOY), UP 20.03% (QOQ) EBITDA UP 17.96% AT ₹104.38 CR (YOY), UP 26.71% (QOQ) MARGINS AT 33.77% VS 35.82% (YOY), 31.99% (QOQ)
CONCORD BIOTECH LIMITED